This post was originally published on this site.
Shares in Datavault were the number one trending ticker on Monday morning, with the penny stock rising 8% in pre-market trading after gaining 30% in the previous session.
The AI company has benefited as concerns over a renewed sell-off in AI-related stocks eased. In a letter to shareholders, Datavault’s (DVLT) chief executive Nathaniel Bradley said the group secured $49m (£36m) in tokenisation and technology licensing agreements during the fourth quarter, deals that he said were expected to contribute to revenues in 2025 and 2026. The letter also set out a target of at least $200m in revenue by 2026.
Bradley said the company’s “guiding principle” was to pursue “national rollouts”, while acknowledging “many challenges that we have to overcome” as it develops cybersecure computing equipment located close to data sources to manage tokenisation and valuation.
He also pointed to a $150m strategic investment from Scilex Holding to support the construction of a supercomputer, as well as tokenisation agreements that could generate up to $8m in fees from a Triton Geothermal token offering and a $7m minting contract with MTB Mining.
Read more: Stocks higher as Starmer faces MPs after chief of staff quits over Mandelson
Datavault (DVLT), which specialises in data licensing and monetisation, has been promoting tokenisation, the conversion of asset rights into blockchain based digital tokens, as a new way to extract value from data and digital assets.
Novo Nordisk’s shares rose over 6% before the US bell on Monday after telehealth firm Hims & Hers (HIMS) reversed the launch of a $49 compounded weight loss pill over the weekend following legal threats from Novo Nordisk and the US Food and Drug Administration.
Hims introduced the pill last Thursday using semaglutide, the active ingredient in Novo Nordisk’s (NVO, NOVO-B.CO) blockbuster treatments Wegovy and Ozempic, prompting objections from the Danish drugmaker and US regulators. On Saturday, Hims said it would stop offering the treatment after holding “constructive conversations with stakeholders”.
Novo Nordisk’s (NVO, NOVO-B.CO) shares had already recovered more than 5% on Friday after FDA commissioner Marty Makary signalled a tougher stance on unauthorised compounded GLP 1 medicines, which have put pressure on the company’s pricing power in the weight loss and diabetes markets.
A consortium led by FedEx Corporation and private equity firm Advent has agreed to buy parcel locker group InPost in a deal worth €7.8bn (£6.8bn).
The bidders have offered €15.60 (£13.59) a share for Polish-headquartered InPost, with plans to expand further across the UK and Europe.
Read more: Stocks to watch this week: BP, Barclays, AstraZeneca, Airbnb and Coinbase
The company will continue to operate under the InPost brand with its headquarters in Poland and with founder and chief executive Rafat Brzoska remaining at the helm.
The deal is expected to complete in the second half of 2026.
Shares in State Bank of India rose 6% to a record high on Monday after the country’s largest lender reported quarterly profit that exceeded expectations and posted industry leading growth in net interest income.
The stock was trading at 1,130 rupees (£9.16), its highest level on record, and was on track for its strongest daily performance since June 2024. It was the top performer on the benchmark Nifty 50 (^NSEI) index and the banking index.
The state backed lender reported standalone net profit of 210.28 billion rupees for the three months to 31 December, up from 168.91 billion rupees a year earlier. Analysts had forecast profit of 173.26 billion rupees, according to data compiled by LSEG.
Net interest income rose 9% to 451.9 billion rupees, supported by growth in domestic lending. Net interest margin, a key measure of profitability, was unchanged at 3.12%.
NatWest Group has agreed to buy wealth management firm Evelyn Partners for £2.7bn, marking the bank’s first major acquisition since returning to private ownership. Shares dropped at the open in London.
The announcement follows reports that the banking group had seen off competition from rival Barclays (BARC.L) for the takeover move.
Acquiring Evelyn, one of the UK’s biggest wealth managers, brings together its £69bn in assets under management with NatWest’s (NWG.L) £59bn.
Stocks: Create your watchlist and portfolio
The London-based firm, which rebranded from Tilney Smith & Williamson in 2022, offers financial planning and investment management and operates consumer platform BestInvest.
The deal is expected to boost NatWest’s (NWG.L) fee income by about a fifth and increase the size of its private banking and wealth management business.
NatWest’s (NWG.L) chief executive Paul Thwaite said: “Bringing together these two leading businesses creates a unique opportunity to provide financial planning, savings and investment services to more families and people across the UK.”
Read more:
Download the Yahoo Finance app, available for Apple and Android.